Making the Cardiorenal Connection with SGLT2 inhibitors
Published: 25 February 2021
-
Views:
13526
-
Likes:
7
-
Views:
13526
-
Likes:
7
-
Up Next
-
21m 13sPart 3 The Renal Connection
-
8m 57sPart 4 All Faculty
-
9m 52sPart 1 Welcome & Introductions Carol Pollock, Mark Petrie, David Cherney
Overview
This educational symposium was part of the eSPACE CRM meeting held on 22-24 January 2021.
The session focuses on latest data and practical implication of SGLT2 Inhibitors in Heart Failure patients.
Learning objectives
This educational symposium will allow the audience to:
- Understand the pathophysiological connections between cardiovascular disease and kidney disease
- Understand how SGLT2 inhibition modifies cardiovascular and kidney function to affect patient outcomes
- Identify individuals at risk of incident and progressive cardiorenal disease and utilise SGLT2 inhibitors appropriately for prevention and treatment of the associated conditions
- Explain how recent guideline updates position SGLT2 inhibitors within the treatment regimen for patients with, or at risk of, cardiorenal disease
Symposium Agenda
Time - Session title and objective - Speaker(s)
- 10 mins - Welcome and Introductions - Carol Pollock
- 20 mins - The Cardiac Connection - Mark Petrie
- 20 mins - The Renal Connection - David Cherney
- 10 mins - Joined-up thinking: Evolving guidelines for cardiorenal disease management - All faculty
More from this programme
Part 1
Welcome & Introductions
| 1 session | |
| Welcome & Introductions | Watch now |
Part 2
The Cardiac Connection
| 1 session | |
| The Cardiac Connection | Watch now |
Part 3
The Renal Connection
| 1 session | |
| The Renal Connection | Watch now |
Part 4
Joined-up thinking: Evolving guidelines for cardiorenal disease management
| 1 session | |
| All Faculty | Watch now |
Faculty Biographies
Mark Petrie
Professor/Honorary Consultant (Institute of Cardiovascular & Medical Sciences)
Prof Mark Petrie is Professor of Cardiology in the Institute of Cardiovascular and Medical Sciences at the University of Glasgow, UK. Prof Petrie started his studies as an undergraduate at Edinburgh University, before training in cardiology in Glasgow. He worked as a heart failure and interventional cardiologist for many years before transferring to the University of Glasgow in 2016.
Prof Petrie's research interests focus on diabetes and cardiovascular disease in heart failure, structural intervention and revascularization in heart failure, peripartum cardiomyopathy, microvascular disease in heart failure with preserved ejection fraction, postmyocardial infarction cardiac remodeling, iron in heart failure, and cardio-oncology. While Prof Petrie has many research interests, he also takes pleasure in mentoring future high-caliber cardiologists and has supervised many outstanding individuals during their PhDs and MDs.